- Description
| Specificity Profile | More Information |
 | The specificity of MET Monoclonal Antibody (CSB0070) was tested on the Membrane Proteome Array™ and shown to be specific for human MET. The Membrane Proteome Array™ contains 6,000 different human membrane proteins, each expressed in unfixed human cells to ensure native conformation and post-translational modifications. The Membrane Proteome Array™ represents the industry standard for determining the binding specificity of antibodies and other protein ligands. |
| Application | Conditions | Recommended Concentration |
| Flow Cytometry, Extracellular | Live, Unpermeabilized | 1 µg/ml |
 | JS-1 cells transiently transfected with human MET were stained with MET Monoclonal Antibody (CSB0070) (green) or isotype control antibody (gray), followed by AlexaFluor 647-conjugated anti-Mouse IgG secondary antibody. JS-1 cells transiently transfected with an empty control vector were also stained with MET Monoclonal Antibody (CSB0070) (blue). | |
| Application | Conditions | Recommended Concentration |
| Immunofluorescence, Extracellular | Fixed 4% paraformaldehyde | 1 µg/ml |
 | (A) JS-1 cells transiently transfected with human MET were stained with MET Monoclonal Antibody (CSB0070) followed by AlexaFluor 647 anti-Mouse IgG secondary antibody (red) and DAPI (blue). (B) JS-1 cells transiently transfected with an empty control vector stained with MET Monoclonal Antibody. (C) Isotype control: JS-1 cells transfected with human MET and stained with control MAb. | |
| Application | Conditions | Recommended Concentration |
| Immunofluorescence, Intracellular | Fixed 4% paraformaldehyde, Permeabilized 0.1% Triton X-100 | 1 µg/ml |
 | (A) JS-1 cells transiently transfected with human MET were permeabilized and stained with MET Monoclonal Antibody (CSB0070) followed by AlexaFluor 647 anti-Mouse IgG secondary antibody (red) and DAPI (blue). (B) JS-1 cells transiently transfected with an empty control vector stained with MET Monoclonal Antibody. (C) Isotype control: JS-1 cells transfected with human MET and stained with control MAb. | |
CSB VeRSaMAbs:
We produce and validate all our monoclonal antibodies in-house so that you can confidently choose the right antibody for your assay. All antibodies are VALIDATED for common applications, RECOMBINANT for batch-to-batch consistency, and SPECIFIC in binding to only your target.
| Target | MET |
| Target Aliases | DFNB97, RCCP2, HGFR, SF Receptor, AUTS9, C-Met |
| Isotype | Mouse IgG2a |
| Membrane Proteome Specificity | Monospecific for 6,000 membrane proteins tested |
| Species Reactivity | Human (others untested) |
| Fc Modifications | C-terminal Avitag, disabled Fc-gamma receptor binding |
| Source | Recombinant CHO expression; purified by Protein A chromatography |
| Formulation | Endotoxin Free PBS pH 7.4, sterile-filtered |
| Concentration | 1 mg/ml |
Stable for 12 months from date of receipt when stored at 4°C. Avoid repeated freeze-thaw cycles.
MET is a single-pass transmembrane protein and receptor tyrosine kinase with a secreted isoform. MET binds hepatocyte growth factor and is involved in embryonic development and cellular migration, invasion, and survival. Mutations in MET are associated with various types of cancer. (NCBI Gene: 4233, UniProtKB/Swiss-Prot: P08581). Other names: DFNB97, RCCP2, HGFR, SF Receptor, AUTS9, C-Met
